Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
August 29 2022 - 7:00AM
Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage
pharmaceutical company with a Research & Development
(“R&D”) innovation engine that aims to discover, develop and
ultimately deliver impactful medicines to patients, today announced
that members of its management team will participate in the
following investor conferences:
Event: Morgan Stanley 20th Annual Global
Healthcare ConferenceDate: Monday, September 12,
2022Location: New York City, NYFireside
Chat: 8:45 AM ET
Event: H.C. Wainwright 24th Annual Global
Investment ConferenceDate: Tuesday, September 13,
2022Location: New York City,
NYPresentation: 1:30 PM ET
Event: Guggenheim
Nantucket Therapeutics ConferenceDate: Wednesday,
September 28, 2022 Location: Nantucket,
MAFireside Chat: 11:30 AM ET
Access to the live webcasts of these events, as well as archived
recordings, will be available under the “Events and Publications”
tab on the investor relations section of the Centessa
Pharmaceuticals website at
https://investors.centessa.com/events-presentations.
About Centessa PharmaceuticalsCentessa
Pharmaceuticals plc is a clinical-stage pharmaceutical company with
an R&D innovation engine that aims to discover, develop and
ultimately deliver impactful medicines to patients. Our programs
span discovery-stage to late-stage development and cover a range of
high-value indications in rare diseases and immuno-oncology. We are
led by a management team with extensive R&D experience,
providing direct guidance to our program teams to rapidly advance
our candidates from research through all stages of development. For
more information, visit www.centessa.com, which does not form part
of this release.
Contact:Kristen K. Sheppard, Esq.SVP of
Investor Relationsinvestors@centessa.com
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From Jul 2024 to Aug 2024
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From Aug 2023 to Aug 2024